Finance Home - My Yahoo - Yahoo! - Help

Tuesday, November 10, 2009, 7:11AM ET - U.S. Markets open in 2 hours and 19 minutes. Dow  2.03% Nasdaq  0.00%

Cleveland BioLabs, Inc. (CBLI)

On Nov 9: 3.88   0.00 (0.00%)

MORE ON CBLI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Nov 2, 2009 • Cleveland BioLabs to Present at Merriman 6th Annual Investor Summit Marketwire (Mon, Nov 2) Tue, Oct 20, 2009 • Cleveland BioLabs to Host Roundtable on Protectan CBLB502 for Acute Radiation Syndrome Marketwire (Tue, Oct 20) Mon, Oct 19, 2009 • Cleveland BioLabs to Present at 8th Annual BIO Investor Forum Marketwire (Mon, Oct 19) Tue, Oct 6, 2009 • Department of Defense Increases Ongoing Contract With Cleveland BioLabs for Developmental Studies Related to Protectan CBLB502 Marketwire (Tue, Oct 6) Mon, Oct 5, 2009 • Rodman & Renshaw Initiates Analyst Coverage of Cleveland BioLabs Marketwire (Mon, Oct 5) Wed, Sep 30, 2009 • Cleveland BioLabs keeps cashing in at bizjournals.com (Wed, Sep 30) • Armed Forces Radiobiology Research Institute and Cleveland BioLabs Awarded Grant From Department of Defense to Study Radioprotective Effects of Protectan CBLB600 Series Marketwire (Wed, Sep 30) Tue, Sep 29, 2009 • More cancer funds for Cleveland BioLabs at bizjournals.com (Tue, Sep 29) • Coverage initiated on Cleveland Biolabs by Rodman & Renshaw Briefing.com (Tue, Sep 29) • Cleveland BioLabs Awarded $5.3 Million Grand Opportunities Grant From National Institutes of Health for Protectan CBLB502 Research in Mitigation of Radiation Damage of GI Tract Marketwire (Tue, Sep 29) Thu, Sep 24, 2009 • Gov't adds to Cleveland BioLabs contract at bizjournals.com (Thu, Sep 24) • Cleveland BioLabs Receives $2.3 Million Addition to $13.3 Million Contract With Biomedical Advanced Research and Development Authority (BARDA) to Develop Radiation Countermeasure Protectan CBLB502 Marketwire (Thu, Sep 24) Tue, Sep 22, 2009 • NIH ups ClevelandBioLabs research at bizjournals.com (Tue, Sep 22) • National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Additional Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage Marketwire (Tue, Sep 22) Mon, Sep 21, 2009 • Cleveland BioLabs to Present at Maxim Group Growth Conference Marketwire (Mon, Sep 21) Tue, Sep 15, 2009 • Oncogene Testing Patents Key In Evaluating Stock Picks In Medical Research Sector According To Industry Expert Wall Street Transcript (Tue, Sep 15) • Cleveland BioLabs Inc. CEO and President Interview: Dr. Michael Fonstein, PhD. Wall Street Transcript (Tue, Sep 15) • Arrowhead Research Corp. CEO and President Interview: Christopher Anzalone Wall Street Transcript (Tue, Sep 15) Mon, Sep 14, 2009 • Stimulus funds lift health research at bizjournals.com (Mon, Sep 14) Sun, Sep 13, 2009 • China Biotech Week in Review: Deals and Products at Seeking Alpha (Sun, Sep 13) Older Headlines - Download Recent Headlines View headlines from: Sun, Sep 13, 2009Sun, Sep 6, 2009Sun, Aug 30, 2009Sun, Aug 23, 2009Sun, Aug 16, 2009Sun, Aug 9, 2009Sun, Aug 2, 2009Sun, Jul 26, 2009Sun, Jul 19, 2009Sun, Jul 12, 2009 Add CBLI News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage